Please use this identifier to cite or link to this item:
https://wslhd.intersearch.com.au/wslhdjspui/handle/1/9563
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Chen, J. | - |
dc.contributor.author | Tu, Thomas | - |
dc.contributor.author | Cohen, C. | - |
dc.contributor.author | Wang, S. | - |
dc.contributor.author | Hsu, Y. C. | - |
dc.contributor.author | Gish, R. G. | - |
dc.date.accessioned | 2024-05-16T03:11:07Z | - |
dc.date.available | 2024-05-16T03:11:07Z | - |
dc.date.issued | 2024 | - |
dc.identifier.citation | Hepatology 79(5):E132-E133, 2024 | - |
dc.identifier.uri | https://wslhd.intersearch.com.au/wslhdjspui/handle/1/9563 | - |
dc.subject | Hepatitis B, Chronic | - |
dc.subject | Liver Cirrhosis | - |
dc.subject | Antiviral Agents | - |
dc.subject | Hepatitis B virus | - |
dc.title | Letter to the Editor: Halting antiviral therapy in patients with cirrhosis and chronic hepatitis B: A dangerous game? | - |
dc.type | Journal Article | - |
dc.identifier.doi | https://dx.doi.org/10.1097/HEP.0000000000000732 | - |
dc.identifier.journaltitle | Hepatology | - |
dc.identifier.department | Storr Liver Centre | - |
dc.contributor.wslhd | Tu, Thomas | - |
dc.type.studyortrial | Letter | - |
dc.identifier.pmid | 38150019 | - |
dc.identifier.facility | Westmead | - |
Appears in Collections: | Westmead Hospital 2019 - 2024 |
Files in This Item:
There are no files associated with this item.
Items in the repository are protected by copyright, with all rights reserved, unless otherwise indicated.